HOME >> MEDICINE >> NEWS
Imatinib (Gleevec) has activity in AIDS-related Kaposi's sarcoma

Alexandria, VA--A new clinical study has shown that imatinib mesylate (Gleevec) has activity in AIDS-related Kaposi's sarcoma (KS). Imatinib inhibits important pathways that spur cancer growth, resulting in the regression of KS tumors within 4 weeks in some patients. The study will be published November 30 in the Journal of Clinical Oncology (JCO).

"Imatinib is a targeted therapy originally shown to be effective in treating chronic myelogenous leukemia and gastrointestinal stromal tumors. This study and others are showing that the drug is also active in other cancers that express some of the same proteins," said Henry B. Koon, MD, Instructor of Medicine, Beth Israel Deaconess Medical Center/Harvard Medical School in Boston, and lead author of the study. "Studies like this one represent an exciting time in oncology, when our understanding of the development of diseases like KS coincide with the availability of effective treatments. Further research on imatinib in KS patients will be needed to determine appropriate dosing schedules."

Kaposi's sarcoma is an AIDS-defining illness characterized by soft purplish lesions on the skin, mucous membranes, and internal organs. Although the incidence of KS has declined dramatically in the developed world since the advent of highly active antiretroviral therapies (HAART), it remains a significant cause of morbidity and mortality for AIDS patients in the United States and a major cause of mortality in the third world, given the limited number of effective treatments for KS.

Researchers examined the response of Kaposi's sarcoma to imatinib, a drug known to inhibit the PDGF-R and/or c-kit pathways that are responsible for the growth of other cancers, such as chronic myelogenous leukemia, gastrointestinal stromal tumors (GIST), and bone sarcomas of the head and neck. Given that PDGF-R and c-kit also play a role in the development of KS, researchers theorized that imatinib may be an effective strategy
'"/>

Contact: Danielle Potuto
potutod@asco.org
703-519-1422
American Society of Clinical Oncology
30-Nov-2004


Page: 1 2

Related medicine news :

1. Imatinib shows early promise against Ewings sarcoma
2. Brain activity prior to treatment flags vulnerability to antidepressant side effects
3. Physical activity linked to protection from Parkinsons disease
4. Brain activity of men and women during hostile or impulsive acts differs less on nicotine
5. Abnormal brain activity during the observation of others actions
6. Increased physical activity not linked to ALS risk
7. Maintaining physical activity linked to less cognitive decline in older men
8. Daily social/physical activity improves sleep and cognition in the elderly
9. Celecoxib shows surprising activity against estrogen receptors
10. Jefferson scientists find way to see breast cancer activity from outside the body
11. Brain activity reflects complexity of responses to other-race faces

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Imatinib Gleevec has activity AIDS related Kaposi sarcoma

(Date:3/6/2015)... March 06, 2015 Last month, Dr. Dental ... oral hygiene and heart health. To mark the occasion, the ... hygiene can positively affect heart health. , According to ... heart health. Experts note that taking good care of oral ... that the two have some commonalities. For example, inflammation is ...
(Date:3/6/2015)... March 06, 2015 A California Superior ... http://www.filevaginalmeshlawsuit.com/ ) filed against Johnson & Johnson and its ... $5.7 million to a woman who suffered serious complications ... treat stress urinary incontinence. In a verdict rendered on ... was defectively designed, and that doctors and patients were ...
(Date:3/6/2015)... Based on recent data from the National Health ... have self-reported, doctor-diagnosed arthritis. And children suffer from ... to those who suffer with arthritis with its “Get ... their purchase when they buy directly from the company, ... a tube of the product will be donated on ...
(Date:3/6/2015)... Protein identification is increasingly being used ... research including drug discovery, diagnostics, immunology and oncology. ... valued at $1,569.00 million in 2014 and is ... to reach $2,600.28 million in 2019. , Protein ... based on protein size, shape, sequence and physiochemical ...
(Date:3/6/2015)... Today, the California Healthcare Institute (CHI), ... Ph.D., Director of the National Institutes of Health (NIH) ... a roundtable discussion regarding the vibrancy of the California ... Obama's Precision Medicine Initiative. , Joint Statement from Dr. ... of the School of Medicine, UC San Diego; Joe ...
Breaking Medicine News(10 mins):Health News:Dr. Dental Celebrates American Heart Month 2Health News:Transvaginal Mesh Lawyers at Bernstein Liebhard Comment on Latest Trial Victory for Ethicon Mesh Lawsuit Plaintiff 2Health News:Transvaginal Mesh Lawyers at Bernstein Liebhard Comment on Latest Trial Victory for Ethicon Mesh Lawsuit Plaintiff 3Health News:Transvaginal Mesh Lawyers at Bernstein Liebhard Comment on Latest Trial Victory for Ethicon Mesh Lawsuit Plaintiff 4Health News:Topical BioMedics Offers Help for Those Who Suffer with Arthritis with New “Get Arthritis Relief” Initiative 2Health News:Topical BioMedics Offers Help for Those Who Suffer with Arthritis with New “Get Arthritis Relief” Initiative 3Health News:Topical BioMedics Offers Help for Those Who Suffer with Arthritis with New “Get Arthritis Relief” Initiative 4Health News:Topical BioMedics Offers Help for Those Who Suffer with Arthritis with New “Get Arthritis Relief” Initiative 5Health News:Protein Identification Market worth $2,600.28 Million By 2019 - New Research Report by MarketsandMarkets 2Health News:Protein Identification Market worth $2,600.28 Million By 2019 - New Research Report by MarketsandMarkets 3Health News:California’s Life Sciences Sector Hosts NIH Director in San Diego 2Health News:California’s Life Sciences Sector Hosts NIH Director in San Diego 3
(Date:3/6/2015)... Glendale-Burbank DNA Justice Project, a $250,000 initiative by the Community ... to its goal thanks to a generous contribution of $50,000 ... was made at a gathering of invited guests who were ... technology utilized by the Glendale and ... Police Chief Robert Castro and ...
(Date:3/6/2015)... CHAPEL HILL, N.C. , March 6, 2015 ... often find it challenging to prove the value ... rapid advances in technology, along with plummeting resources, ... According to recent research by ... forces of change impacting corporate library services. Many ...
(Date:3/6/2015)... March 6, 2015 Patient-oriented programs have risen ... payers have placed more emphasis on patient outcomes and ... healthcare decisions. Across the industry, organizations ... labeled in pharma). You don,t have to ... a Chief Patient Officer to its executive ranks or ...
Breaking Medicine Technology:DNA Lab Gets Generous Boost From the Cusumano Family Foundation 2Forces of Change Impacting Corporate Library Services 2Pharmaceutical Industry Making Adjustments to Include Patient Perspective across Medical and Commercial Operations 2
Cached News: